Tepmetko 225mg Tablet: Effective Relief for Your Condition

Uses:

• Treatment of non-small cell lung cancer (NSCLC) with a mutation in the MET gene.

Therapeutic Effects:

• Anti-tumor effect leading to tumor shrinkage and improved disease control.
• Significantly improves progression-free survival (PFS) in patients with NSCLC compared to standard chemotherapy.

Interaction with Other Drugs:

• Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
• Certain medications may interact with Tepmetko 225mg Tablet, reducing effectiveness or causing undesirable side effects.

Storage:

• Store in a refrigerator between 20–25°C (68–77°F).
• Keep away from moisture, heat, and light.
• Do not freeze.
• Keep in original packaging until use.
• Keep out of reach of children and pets.

How to Consume:

• Take exactly as prescribed by your doctor.
• Recommended dose and schedule may vary.
• Take with food.
• Swallow whole with a glass of water.
• Do not chew, crush, or break the tablet.
• Avoid doubling the dose to compensate for a missed dose.

Safety Advice:

• Pregnancy: consult healthcare provider before use.
• Breastfeeding: consult healthcare provider before use.
• Lungs: can cause lung problems, such as interstitial lung disease (ILD) or pneumonitis.
• Liver: avoid use in patients with severe liver disease.
• Alcohol: avoid consuming alcohol before or after taking Tepmetko 225mg Tablet.
• Driving: monitor response to medication and be cautious when driving or operating machinery if experiencing side effects.

Side Effects:

• Serious: hepatotoxicity, interstitial lung disease (ILD), severe skin reactions, gastrointestinal perforation or fistula formation, bleeding.
• Common: edema (swelling), nausea, diarrhea, fatigue, anorexia (loss of appetite), vomiting, increased blood creatinine levels, increased ALT and AST levels, rash or itching, muscle pain or weakness.

Word of Advice:

• Follow doctor's instructions carefully.
• Contact doctor immediately if experiencing unusual symptoms or side effects.
• Do not stop medication without consulting doctor.
• Pregnant and breastfeeding women should consult with a healthcare provider before taking it.
• Avoid close contact with an infected person.
• Maintain a healthy and balanced diet.

FAQs:

1. Can Tepmetko 225mg Tablet cause high blood pressure?

• Yes, Tepmetko 225mg Tablet can cause or worsen pre-existing hypertension. Patients receiving this medicine should monitor their blood pressure regularly during treatment, and antihypertensive medications may be necessary to control hypertension.

2. What are the potential skin reactions associated with Tepmetko 225mg Tablet?

• Tepmetko 225mg Tablet can cause severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Patients should be monitored for skin rash, blistering, or peeling, and treatment should be discontinued if severe skin reactions occur.

3. Can Tepmetko 225mg Tablet affect renal function?

• Yes, Tepmetko 225mg Tablet may cause renal impairment, and patients with pre-existing renal impairment may be at an increased risk of developing renal toxicity. Patients should have their renal function monitored regularly during treatment.

4. Is there a risk of cataracts with Tepmetko 225mg Tablet?

• Yes, there is a potential risk of developing cataracts using Tepmetko 225mg Tablet. Patients receiving it should check their vision regularly during treatment, and treatment should be discontinued if cataracts develop.

5. Can Tepmetko 225mg Tablet affect fertility?

• There is currently no information on whether Tepmetko 225mg Tablet affects human fertility. However, animal studies have shown that this medication may cause reversible testicular toxicity in male rats. Patients who are planning to have children or are experiencing fertility problems should discuss their concerns with their healthcare provider before starting treatment.

Fact Box:

• Molecule name: Tepotinib
• Therapeutic class: Anticancer
• Pharmacological class: Tyrosine Kinase Inhibitor
• Indications: Treatment of non-small cell lung cancer (NSCLC)

Tags: medical, pain_relief, analgesic, drug, pharmacy, healthcare, medicament, anti_inflammatory, pain_killer